Z Gastroenterol 2016; 54(05): 454-455
DOI: 10.1055/s-0042-100679
Kommentiertes Referat
© Georg Thieme Verlag KG Stuttgart · New York

Methotrexat als Therapieoption bei Patienten mit Colitis ulcerosa?

News on the impact of Methotrexate as therapeutic option in patients with ulcerative colitis
C. Ott
Further Information

Publication History

Publication Date:
12 May 2016 (online)

Carbonnel F, Carbonne JF, Filippi J, Katsanos KH, Peyrin-Biroulet L, Allez M, Nachury M, Novacek G, Danese S, Abitbol V, Bossa F, Moreau J, Bommelaer G, Bourreille A, Fumery M, Roblin X, Reinisch W, Bouhnik Y, Brixi H, Seksik P, Malamut G, FäFrtti M, Coulibaly B, Dewit O, Louis E, Deplanque D, Michetti P, Erre Miche H, Laharie D; European Crohn’u and Colitis Organisation and the Groupe d’Étude Thérapeutique des Affections Inflammatoires Digestives. Methotrexate Is Not Superior to Placebo for Inducing Steroid-Free Remission, but Induces Steroid-Free Clinical Remission in a Larger Proportion of Patients With Ulcerative Colitis. Gastroenterology. 2015 Nov 26. pii: S0016 – 5085(15)01 726 – 6. doi: 10.1053/j.gastro.2015.10.050.